Coronary Revascularization and Long-Term Survivorship in Chronic Coronary Syndrome.

Autores de INCLIVA
Participantes ajenos a INCLIVA
- Bayes-Genis, Antoni
- Husser, Oliver
Grupos y Plataformas de I+D+i
Abstract
Ischemic heart disease (IHD) persists as the leading cause of death in the Western world. In recent decades, great headway has been made in reducing mortality due to IHD, based around secondary prevention. The advent of coronary revascularization techniques, first coronary artery bypass grafting (CABG) surgery in the 1960s and then percutaneous coronary intervention (PCI) in the 1970s, has represented one of the major breakthroughs in medicine during the last century. The benefit provided by these techniques, especially PCI, has been crucial in lowering mortality rates in acute coronary syndrome (ACS). However, in the setting where IHD is most prevalent, namely chronic coronary syndrome (CCS), the increase in life expectancy provided by coronary revascularization is controversial. Over more than 40 years, several clinical trials have been carried out comparing optimal medical treatment (OMT) alone with a strategy of routine coronary revascularization on top of OMT. Beyond a certain degree of symptomatic improvement and lower incidence of minor events, routine invasive management has not demonstrated a convincing effect in terms of reducing mortality in CCS. Based on the accumulated evidence more than half a century after the first revascularization procedures were used, invasive management should be considered in those patients with uncontrolled symptoms despite OMT or high-risk features related to left ventricular function, coronary anatomy, or functional assessment, taking into account the patient expectations and preferences.
Datos de la publicación
- ISSN/ISSNe:
- 2077-0383, 2077-0383
- Tipo:
- Article
- Páginas:
- 610-610
- DOI:
- 10.3390/jcm10040610
- PubMed:
- 33562869
Journal of Clinical Medicine MDPI
Citas Recibidas en Web of Science: 9
Documentos
Filiaciones
Keywords
- chronic coronary syndrome; coronary artery disease; ischemia; ischemic heart disease; myocardial revascularization; stress cardiac magnetic resonance
Financiación
Proyectos y Estudios Clínicos
INCORPORACIÓN DE NUEVAS ÁREAS TEMÁTICAS Y NUEVOS GRUPOS AL CONSORCIO CIBER
Investigador Principal: VICENT BODÍ PERIS
CB16/11/00486 . INSTITUTO SALUD CARLOS III
INCORPORACIÓN DE NUEVAS ÁREAS TEMÁTICAS Y NUEVOS GRUPOS AL CONSORCIO CIBER
Investigador Principal: JUAN SANCHIS FORES
CB16/11/00420 . INSTITUTO SALUD CARLOS III
Estudio multidisciplinar de la obstrucción microvascular y su reparación tras un infarto agudo de miocardio: de la arteria coronaria a la microcirculación. Foco en el factor VEGF-A165b (PI17/01836).
Investigador Principal: VICENT BODÍ PERIS
PI17/01836 . INSTITUTO SALUD CARLOS III . 2018
Resolution of microvascular obstruction after myocardial infarction. A multidisciplinary approach to assess the structural and clinical consequences and to evaluate new therapeutic options.
Investigador Principal: VICENT BODÍ PERIS
PI20/00637 . INSTITUTO SALUD CARLOS III . 2021
Cita
Gabaldon A,Marcos V,Gavara J,Rios C,Minana G,Bayes A,Husser O,Sanchis J,Nunez J,Chorro FJ,Bodi V. Coronary Revascularization and Long-Term Survivorship in Chronic Coronary Syndrome. J. Clin. Med. 2021. 10. (4):p. 610-610. IF:4,964. (2).
Coronary Revascularization and Long-Term Survivorship in Chronic Coronary Syndrome. Gabaldon A, Marcos V, Gavara J, Rios C, Minana G, Bayes A, Husser O et al. Journal of Clinical Medicine. 2021 febrero 05. 10 (4):610-610. DOI:10.3390/jcm10040610. PMID:33562869.